HOME     SCHEDULE     AUTHOR INDEX     SUBJECT INDEX         

PARENT SESSION
11:15 AM to 12:15 PM
Monday, April 22, 2002
Plenary Lecture 4
ST1571: A Tyrosine Kinase Inhibitor for the Treatment of CML - Validating the Promise of Molecularly Targeted Therapy
Room: Tahoe

(L04) The BCR-ABL Tyrosine Kinase Inhibitor: A Paradigm for Translational Research.
Druker, Brian*,1, 1 Oregon Health & Science University, Portland, OR
FULL ABSTRACT